Teleflex closes $276M LMA buyout | Wall Street Beat

MassDevice.com Wall Street Beat

Teleflex (NYSE:TFX) said it’s closed the $276 buyout of surgical mask maker LMA International.

The deal brings Singapore-based LMA’s branded laryngeal mask supraglottic airway and its Intavent Direct Ltd. businesses under the Teleflex umbrella.

"These acquisitions will be complementary to Teleflex’s current anesthesia and respiratory businesses, creating a stronger, more diversified business segment with more than $530 million in combined annual sales," chairman, president and CEO Benson Smith said when the deal was announced in August. "The addition of these businesses significantly strengthens and expands our global anesthesia product portfolio, providing opportunities with respect to key clinical U.S. and international call points, while also further strengthening our GPO relationships."

Sign up to get our free newsletters delivered straight to your inbox

At the time Teleflex also said that the deal is expected to add 3¢-4¢ to its adjusted earnings per share during fiscal 2012 and 35¢-40¢ in fiscal 2013.

"From a longer-term perspective, getting a more robust product pipeline is just an important gap that we need to fill," Smith told analysts during a conference call, citing Teleflex’s $80 million buyout of Semprus BioSciences in June and a $15 million deal for Hotspur in July.

Those buys were designed to add to its product pipeline, he said, adding that Teleflex would also look for "share enhancers" for its existing businesses – a niche the LMA deal seems to fulfill.

"We do expect and believe that we can find some other acquisitions within the confines of our current franchises, which I’ll describe as sort of ‘share enhancers’ that give us a much firmer position in some of our existing franchises," Smith said during the July 31 call.

 Zoll establishes Japanese subsidiary
Zoll Medical, which was acquired by Asahi Kasei in for $YY billion in YY, said it’s launching a Japanese subsidiary, Asahi Kasei Zoll Medical Corp., effective Nov. 5.

The new Tokyo-based subsidiary will be led by president Seiji Sakano, reporting Zoll CEO Richard Packer.

"This subsidiary, headed by Dr. Sakano, who previously held the position of general manager of Asahi Kasei’s Advanced Medical Device Center, represents a solid opportunity to enter a high-growth market,"Packer said in prepared remarks. "AZM will leverage the resources of the Asahi Kasei Group to facilitate these developments for the swift expansion of Zoll’s business in Japan."
Read more

 AirStrip, Spine Restoration land $15M

AirStrip Technologies and its suite of apps to allow physicians real-time access to patient vital signs and other clinical data, landed more than $10 million from the Wellcome Trust, CEO Alan Portela told Xconomy. AirStrip, which last week sued mVisum for patent infringement, won FDA clearance in 2010 and CE Mark approval in January for its remote monitoring solution.

Austin, Texas-based Spine Restoration said it closed a $5 million round it plans to use to fund the biologic license application submission and early commercialization for its Biostat tissue sealing system. The funding includes a $3 million equity round from current investors Austin Ventures, Santé Ventures and MB Venture Partners, plus a $2 million in debt from Comerica Bank.
Read more

 Cambridge Heart wins debt reprieve
Cambridge Heart (NSDQ:CAMH) said it won a reprieve from creditors for its 8% secured convertible promissory notes in return for issuing another $300,000 worth of debt. The deal called for Cambridge Heart to make interest payment Oct. 1 and Jan. 1, 2013, but creditors agreed to forego those payments until March 31, 2013, or until the medical device company has enough cash to make the payment or goes bankrupt.
Read more

 GPOs: Premier inks deals for used surgical suites

Premier Healthcare Alliance said it struck deals with Steris (NYSE:STE), Future Health Concepts, Heartland Medical Sales & Services, Metropolitan Medical Services of NC and World Medical Equipment for used surgical suites.

Premier also said it inked a deal with Designs For Vision, Integra Luxtex, SheerVision and Sunoptic Technologies for surgical headlights.  
Read more

 Analysts’ ups and downs

  • Amgen (NSDQ:AMGN): BMO raises estimates, sets "market perform" rating, new $83 price target.
  • C.R. Bard (NYSE:BCR): Mizuho lowers price target from $93 to $88, sets "neutral" rating.
  • Danaher (NYSE:DHR): J.P. Morgan reiterates “overweight” rating, lowers price target from $61 to $59.
  • Edwards Lifesciences (NYSE:EW): Wunderlich lowers price target from $104 to $98, maintains “hold” rating.
  • Intuitive Surgical (NSDQ:ISRG): Mizuho raises price target from $540 to $565, sets “buy” rating; Zacks reaffirms "neutral" rating, sets $563 price target.
  • NuVasive Inc. (NSDQ:NUVA): TheStreet Ratings downgrades from "hold" to "sell" rating.
  • Stryker (NYSE:SYK): S&P Capital IQ cuts from “buy” to “hold” rating.
  • Vascular Solutions (NSDQ:VASC): Feltl & Co. reiterates “buy” rating, raises price target to $16.25.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply